Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Antiepileptic Drugs Industry By 2029?

Over the past few years, the market size for antiepileptic drugs has seen consistent growth. It is projected to increase from $17.01 billion in 2024 to $17.83 billion in 2025, with a compound annual growth rate (CAGR) of 4.8%. Factors that contributed to the growth during the historic period include a higher occurrence rate of epilepsy, enhanced knowledge about neurological conditions, advancements in the development of drugs, government support and funding for epilepsy studies, and the growth of the healthcare infrastructure in developing markets.

The market for antiepileptic drugs is projected to experience substantial expansion in the upcoming years. The market value is predicted to reach “$21.77 billion by 2029”, growing at a compounded annual growth rate of 5.1%. Key factors behind this growth during the forecast period include the increasing prevalence of drug-resistant epilepsy patients, the advancement of customised medications in epilepsy treatment, the growing popularity of biologic and gene therapies, augmented investment in epilepsy research and development, and progress in diagnostics resulting in improved epilepsy case detection. Prominent trends expected during this forecast period encompass the evolution of personalised treatments for epilepsy, improvements in combination therapies addressing drug-resistant epilepsy, emerging therapies targeting specific genetic mutations, an amplified emphasis on the creation of less toxic, yet more potent antiepileptic drugs (AEDs), and growing implementation of cannabidiol-based interventions in seizure management.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24145&type=smp

What Drivers Are Accelerating Expansion Of The Antiepileptic Drugs Market?

The escalating occurrence of epilepsy is anticipated to boost the expansion of the antiepileptic drugs market in the future. Epilepsy is a neurological disorder marked by repeated, unwarranted seizures caused by unusual electrical activity in the brain. The rising count of head injuries due to accidents heightens the probability of epilepsy resulting from brain damage and neural health issues. Antiepileptic drugs (AEDs) manage brain functionality by adjusting neurotransmitters and ion channels, preventing excessive neuron firing. They mitigate the frequency and severity of seizures, enhancing life quality for people with epilepsy. For instance, according to Epilepsy Action, a UK charity providing information and support for individuals with epilepsy, about 630,000 people, which is approximately one in every 100, are living with epilepsy as of February 2022. Around 80 new epilepsy cases are identified daily. Consequently, the escalating occurrence of epilepsy is fueling the expansion of the antiepileptic drug market.

What Are The Key Segment Trends Observed In The Antiepileptic Drugs Market?

The antiepileptic drugs market covered in this report is segmented –

1) By Drug: First Generation, Second Generation, Third Generation

2) By Form: Dry, Liquid

3) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores

Subsegments:

1) By First Generation: Phenobarbital, Phenytoin, Carbamazepine, Valproate, Primidone, Ethosuximide

2) By Second Generation: Lamotrigine, Gabapentin, Topiramate, Levetiracetam, Oxcarbazepine, Tiagabine, Felbamate, Zonisamide

3) By Third Generation: Lacosamide, Eslicarbazepine Acetate, Perampanel, Brivaracetam, Cenobamate

Which Disruptive Trends Are Driving Change Across The Antiepileptic Drugs Market?

Top corporations in the antiepileptic drugs market are concentrating on the production of cutting-edge products such as antiepileptic drugs in Intravenous (IV) formulation. These drugs serve as efficient forms of treatment for acute seizures and emergencies. These medications, applied through an injection or infusion, directly penetrate the bloodstream and provide swift seizure control, especially during urgent situations or when oral drugs fail to deliver expected results. A case in point is Eisai Co., Ltd., a pharmaceutical firm based in Japan, which achieved manufacturing and marketing consent for Fycompa in Japan in January 2024. Fycompa, a groundbreaking, highly selective, and non-competitive AMPA receptor antagonist, curtails neuronal hyperactivity associated with seizures by acting upon glutamate activity at AMPA receptors. An IV formula of Fycompa was conceived as an alternate treatment for epilepsy patients unable to consume the drug orally for a short period, such as during surgery, to avert seizure-related risks connected with the halt of oral administration. Fycompa has attained approval in over 75 countries worldwide and is used to supplement treatment for partial-onset seizures and primary generalized tonic-clonic seizures in Japan for patients who are 4 years and older.

Who Are The Leading Companies Driving The Antiepileptic Drugs Market?

Major companies operating in the antiepileptic drugs market are Pfizer Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., UCB S.A., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Jazz Pharmaceuticals plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Supernus Pharmaceuticals Inc., SK Biopharmaceuticals Co. Ltd., Immedica Pharma AB, Neurelis Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antiepileptic-drugs-global-market-report

Which Region Is Forecasted To Lead The Antiepileptic Drugs Market In The Coming Years?

North America was the largest region in the antiepileptic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antiepileptic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24145&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model